Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_assertion type Assertion NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_head.
- NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_assertion wasGeneratedBy ECO_0000203 NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_provenance.
- NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_assertion wasDerivedFrom befree-2016 NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_provenance.
- NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_assertion SIO_000772 17699277 NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_provenance.
- NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_assertion evidence source_evidence_literature NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_provenance.
- NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_provenance.